Brorson K[au] - Search Results

Year	Number of Results
1989	4
1990	1
1991	2
1992	2
1993	1
1994	1
1995	1
1997	1
1999	1
2000	1
2001	1
2002	2
2003	4
2004	2
2005	5
2006	1
2007	2
2008	4
2009	12
2010	8
2011	8
2012	10
2013	8
2014	10
2015	6
2016	12
2017	12
2018	9
2019	6
2020	3
2022	1

1

Farewell and Thanks!

Brorson K, Junker B, Moreira A, Rathore A, Ricci M, Rao G. Brorson K, et al. PDA J Pharm Sci Technol. 2018 May-Jun;72(3):222. doi: 10.5731/pdajpst.2018.001107. PDA J Pharm Sci Technol. 2018. PMID: 29915145 No abstract available.

2

Hybridoma cell-culture and glycan profile dataset at various bioreactor conditions.

Bhatia H, Read E, Agarabi C, Brorson K, Lute S, Yoon S. Bhatia H, et al. Among authors: brorson k. Data Brief. 2016 Oct 13;9:676-678. doi: 10.1016/j.dib.2016.10.003. eCollection 2016 Dec. Data Brief. 2016. PMID: 27790631 Free PMC article.

3

N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.

Sha S, Agarabi C, Brorson K, Lee DY, Yoon S. Sha S, et al. Among authors: brorson k. Trends Biotechnol. 2016 Oct;34(10):835-846. doi: 10.1016/j.tibtech.2016.02.013. Epub 2016 Mar 22. Trends Biotechnol. 2016. PMID: 27016033 Review.

4

PDA/FDA Virus & TSE Safety Conference.

Brorson K. Brorson K. PDA J Pharm Sci Technol. 2016 Mar-Apr;70(2):93. doi: 10.5731/pdajpst.2016.001095. PDA J Pharm Sci Technol. 2016. PMID: 27081149 No abstract available.

5

Bioprocess: Robustness with Respect to Mycoplasma Species.

Faison T, Wang J, Johnson S, Brown M, Chiang MJ, Dolan S, Breuning C, Velugula-Yellela SR, Lute S, Fratz-Berilla EJ, Brorson K. Faison T, et al. Among authors: brorson k. PDA J Pharm Sci Technol. 2020 Mar-Apr;74(2):201-212. doi: 10.5731/pdajpst.2018.009613. Epub 2019 Sep 13. PDA J Pharm Sci Technol. 2020. PMID: 31519782

6

Industry and regulatory experience of the glycosylation of monoclonal antibodies.

Read EK, Park JT, Brorson KA. Read EK, et al. Among authors: brorson ka. Biotechnol Appl Biochem. 2011 Jul-Aug;58(4):213-9. doi: 10.1002/bab.35. Biotechnol Appl Biochem. 2011. PMID: 21838794 Review.

7

The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.

Fisher AC, Kamga MH, Agarabi C, Brorson K, Lee SL, Yoon S. Fisher AC, et al. Among authors: brorson k. Trends Biotechnol. 2019 Mar;37(3):253-267. doi: 10.1016/j.tibtech.2018.08.008. Epub 2018 Sep 18. Trends Biotechnol. 2019. PMID: 30241924 Review.

8

Post-translational structural modifications of immunoglobulin G and their effect on biological activity.

Hmiel LK, Brorson KA, Boyne MT 2nd. Hmiel LK, et al. Among authors: brorson ka. Anal Bioanal Chem. 2015 Jan;407(1):79-94. doi: 10.1007/s00216-014-8108-x. Epub 2014 Sep 10. Anal Bioanal Chem. 2015. PMID: 25200070 Review.

9

Adapting viral safety assurance strategies to continuous processing of biological products.

Johnson SA, Brown MR, Lute SC, Brorson KA. Johnson SA, et al. Among authors: brorson ka. Biotechnol Bioeng. 2017 Jan;114(1):21-32. doi: 10.1002/bit.26060. Epub 2016 Aug 17. Biotechnol Bioeng. 2017. PMID: 27474890 Review.

10

Multi-Attribute Method for Quality Control of Therapeutic Proteins.

Rogstad S, Yan H, Wang X, Powers D, Brorson K, Damdinsuren B, Lee S. Rogstad S, et al. Among authors: brorson k. Anal Chem. 2019 Nov 19;91(22):14170-14177. doi: 10.1021/acs.analchem.9b03808. Epub 2019 Nov 4. Anal Chem. 2019. PMID: 31618017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results